Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Celldex Therapeutics (CLDX) Change in Acquisitions & Divestments (2016 - 2025)

Celldex Therapeutics has reported Change in Acquisitions & Divestments over the past 16 years, most recently at $111.5 million for Q4 2025.

  • Quarterly results put Change in Acquisitions & Divestments at $111.5 million for Q4 2025, down 27.59% from a year ago — trailing twelve months through Dec 2025 was $596.3 million (up 18.85% YoY), and the annual figure for FY2025 was $596.3 million, up 18.85%.
  • Change in Acquisitions & Divestments for Q4 2025 was $111.5 million at Celldex Therapeutics, down from $116.9 million in the prior quarter.
  • Over the last five years, Change in Acquisitions & Divestments for CLDX hit a ceiling of $195.0 million in Q1 2025 and a floor of $13.0 million in Q3 2021.
  • Median Change in Acquisitions & Divestments over the past 5 years was $84.6 million (2022), compared with a mean of $93.7 million.
  • Peak annual rise in Change in Acquisitions & Divestments hit 562.38% in 2022, while the deepest fall reached 64.3% in 2022.
  • Celldex Therapeutics' Change in Acquisitions & Divestments stood at $45.9 million in 2021, then soared by 91.09% to $87.8 million in 2022, then dropped by 19.26% to $70.9 million in 2023, then skyrocketed by 117.2% to $154.0 million in 2024, then decreased by 27.59% to $111.5 million in 2025.
  • The last three reported values for Change in Acquisitions & Divestments were $111.5 million (Q4 2025), $116.9 million (Q3 2025), and $172.8 million (Q2 2025) per Business Quant data.